T2 Biosystems, Inc. Realized Gains on Marketable Securities
T2 Biosystems, Inc. reported Realized Gains on Marketable Securities of -$14.00 thousand for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-04.
Discontinued › Income Statement › Other Income
us-gaap:MarketableSecuritiesRealizedGainLoss · last filed 2021-11-04
- T2 Biosystems, Inc. marketable securities, realized gain (loss) for the quarter ending 2021-09-30 was $0.00.
- T2 Biosystems, Inc. marketable securities, realized gain (loss) for the quarter ending 2021-06-30 was -$12.00K.
- T2 Biosystems, Inc. marketable securities, realized gain (loss) for the quarter ending 2021-03-31 was -$2.00K.
- T2 Biosystems, Inc. marketable securities, realized gain (loss) for the quarter ending 2020-12-31 was -$3.00K.
- T2 Biosystems, Inc. marketable securities, realized gain (loss) for fiscal 2020 was -$4.00K.
| Period end | Marketable Securities, Realized Gain (Loss) 3 month | Marketable Securities, Realized Gain (Loss) 6 month | Marketable Securities, Realized Gain (Loss) 9 month | Marketable Securities, Realized Gain (Loss) 12 month |
|---|---|---|---|---|
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$12.00K derived: sum of 2 quarters · filed 2021-11-04 | -$14.00K 10-Q · filed 2021-11-04 | -$17.00K derived: sum of 4 quarters · filed 2021-11-04 |
| 2021-06-30 | -$12.00K 10-Q · filed 2021-08-09 | -$14.00K 10-Q · filed 2021-08-09 | -$17.00K derived: sum of 3 quarters · filed 2021-08-09 | -$18.00K derived: sum of 4 quarters · filed 2021-11-04 |
| 2021-03-31 | -$2.00K 10-Q · filed 2021-05-13 | -$5.00K derived: sum of 2 quarters · filed 2021-05-13 | -$6.00K derived: sum of 3 quarters · filed 2021-11-04 | |
| 2020-12-31 | -$3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | -$4.00K derived: sum of 2 quarters · filed 2021-11-04 | -$4.00K 10-K · filed 2021-03-31 | |
| 2020-09-30 | -$1.00K 10-Q · filed 2021-11-04 | -$1.00K 10-Q · filed 2021-11-04 |